CAMRAS, CB. Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of tretment in 198 patients. Latanoprost Study Groups. Ophthalmology. 1996, 103, 1916-1924
WATSON, PG. Latanoprost, Two years'experience of its use in the United Kingdom. Latanoprost Study Group. Ophthalmology. 1998, 105, 82-87
MASTROPASQUA, L. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Ophthalmology. 1999, 106, 550-555
ALM, A. Effects on Intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology. 1995, 102, 1743-1752
WISTRAND, PJ. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color. Surv Ophthalmol. 1997, 41, 129-138